Aspects of our liver support systems using extracorporeal xenoperfusion of pig or baboon liver: Review

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 8, Issue 1, 2001, Pages 27-39

  Shimahara, Yasuyuki ^a   Terajima, Hiroaki ^a   Ikai, Iwao ^a   Yamaoka, Yoshio ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Artificial liver support; Humoral injury; Hyperacute rejection; Liver failure; Metabolic support; Xenoperfusion

Indexed keywords

COMPLEMENT MEMBRANE ATTACK COMPLEX;

ANIMAL; ARTIFICIAL LIVER; ARTIFICIAL MEMBRANE; EQUIPMENT DESIGN; EXTRACORPOREAL CIRCULATION; GRAFT REJECTION; LIVER; LIVER FAILURE; METABOLISM; METHODOLOGY; PAPIO; PATHOPHYSIOLOGY; RENAL REPLACEMENT THERAPY; REVIEW; SWINE; VASCULARIZATION;

ANIMALS; COMPLEMENT MEMBRANE ATTACK COMPLEX; EQUIPMENT DESIGN; EXTRACORPOREAL CIRCULATION; GRAFT REJECTION; LIVER; LIVER FAILURE; LIVER, ARTIFICIAL; MEMBRANES, ARTIFICIAL; PAPIO; RENAL DIALYSIS; SWINE;

EID: 0035234948     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005340170048     Document Type: Article

References (65)

1. Brunner G, Schmidt FW (1981) Artificial liver support. Springer Verlag, Berlin Heidelberg New York Tokyo
2. Brunner G, Mito M (1992) Artificial liver support, 2nd edn: concept, methods, results. Springer Verlag, Berlin Heidelberg New York London Paris Tokyo Hong Kong Barcelona Budapest
3. Dowling DJ, Mutimer DJ (1999) Artificial liver support in acute liver failure. Eur J Gastroenterol Hepatol 11:991-996
4. Neuhaus P, Steffen R (1989) Medical aspects of the artificial liver. Langenbecks Arch Chir Suppl Kongressbd 301:301-307
5. Yoshiba M, Sekiyama K, Iwamura Y, Sugata F (1993) Development of reliable artificial liver support (ALS): plasma exchange in combination with hemodiafiltration using high-performance membranes. Dig Dis Sci 38:469-476
6. Eisman B, Liem DS, Raffucci F (1965) Heterologous liver perfusion in treatment of hepatic failure. Ann Surg 162:329-335
7. Abouna GM (1968) Experience with extracorporeal pig liver perfusion in the treatment of hepatic coma. Gut 9:509-510
8. Abouna GM, Fisher LM, Porter KA, Andres G (1973) Experience in the treatment of hepatic failure by intermittent liver hemoperfusions. Surg Gynecol Obstet 137:741-752
9. Lie TS, Gutgemann A, Siedeck M, Rommelsheim K, Muller J, Dengler HJ, Lelbach WK (1978) Extracoporeal vital liver perfusion in the treatment of acute hepatic coma. Med Klin 73:124-129
10. Gundermann KJ, Lie TS (1980) Treatment of acute hepatic failure by hemoperfusion over baboon and human livers: alphafetoprotein levels in serum. Artif Organs 4:27-92
11. Yamaoka Y, Oshita M, Ozawa K, Olumide F, Eiseman-B (1980) Effect of insulin on donor hepatic energy charge during cross-dialysis liver support. World J Surg 4:117-121
12. Kamiyama Y, Ozawa K, Honjo I (1976) Changes in mitochondrial phosphorylative activity and adenylate energy charge of regenerating rabbit liver. J Biochem 80:875-881
13. Atkinson DE (1968) The energy charge of the adenylate pool as a regulatory parameter, interaction with feedback modifiers. Biochemistry 7:4030-4034
14. Ozawa K, Yamaoka Y, Kimura K, Kamiyama Y, Sato M, Ukikusa M, Tobe T (1981) Circulating hepatodepressant factors decreasing the energy charge levels of the remnant liver after hepatectomy. Eur Surg Res 13:444-457
15. Ukikusa M, Ozawa K, Shimahara Y, Sawanishi K, Tobe T (1981) The effects of cross-circulation and charcoal hemoperfusion on adenylate energy charge of the remnant liver after major hepatic resection. Artif Organs 5:67-71
16. Ozawa K, Kamiyama Y, Kimura K, Ukikusa M, Kono Y, Yamato T, Shimahara Y, Nakatani T, Asano M, Irie-R, Kawashima S, Uchida K, Ohtoshi M, Aoyama H, Hirai F, Yasuda K, Tobe T (1982) The effects of heterologous liver cross-hemodialysis on adenylate energy charge of the remnant liver after major hepatic resection. Artif Organs 6:447-452
17. Ozawa K, Kamiyama Y, Kimura K, Ukikusa M, Kono Y, Yamato T, Shimahara Y, Nakatani T, Asano M, Irie R, Kawashima S, Uchida K, Ohtoshi M, Aoyama H, Hirai F, Yasuda K, Tobe T (1982) Clinical experience of postoperative hepatic failure treatment with pig or baboon liver cross-hemodialysis with an interposed membrane. Artif Organs 6:433-446
18. Yamamoto M, Sato M, Ida T, Ukigusa M, Ozawa K (1978) Obstructive jaundice and hemorrhagic shock. Circ Shock 5:235-249
19. Tanaka J, Ozawa K, Tobe T (1979) Significance of blood ketone body ratio as an indicator of hepatic cellular energy status in jaundiced rabbits. Gastroenterology. 76:691-696
20. Ozawa K (1983) Biological significance of mitochondrial redox potential in shock and multiple organ failure - redox theory. In: Lefer AM, Schumer W (eds) Molecular and cellular aspects of shock and trauma. Alan R Liss, New York, pp 39-66
21. Asano M, Ozawa K, Tobe T (1983) Postoperative prognosis as related to blood kctonc body ratios in hcpatcctomizcd patients. Eur Surg Res 15:302-311
22. Shimahara Y, Kiuchi T, Yamamoto Y, Yamaguchi T, Takada Y, Yamauchi A, Higashiyama H, Egawa H, Kobayashi N, Mori K, Yamaoka Y, Kumada K, Ozawa K (1990) Hepatic mitochondrial redox potential and nutritional support in liver insufficiency. In: Tanaka T, Okada A (eds) Nutritional support in organ failure. Elsevier Science, Amsterdam, pp 295-308
23. Ozawa K, Kamiyama Y, Ukikusa M, Tobe T (1981) Significance of hepatic energy charge and blood ketone body ratio as criteria of liver support. Indication and efficacy in hepatectomized patients during cross dialysis. In: Brunner G, Schmidt FW (eds) Artificial liver support. Springer Verlag, Berlin Heidelberg New York, pp 164-169
24. Ozawa K, Kamiyama Y, Kimura K, Yamada T, Yamamoto M (1977) Comparison of subcutaneous and intraportal insulin administrations on adenylate energy charge of the liver in diabetic rats. J Lab Clin Med 89:937-945
25. Ida T, Yamamoto M, Yamada T, Ozawa K, Honjo I, Kamano T, Garbus J, Cowley RA (1979) Energy response in the liver of diabetic rats to hemorrhagic shock: physiologic significance of decreased insulin response. Am Surg 45:238-245
26. Yamaoka Y, Oshita-M, Ozawa K, Olumide F, Eiseman B (1980) Effect of insulin on donor hepatic energy charge during cross-dialysis liver support. World J Surg 4:117-121
27. Ukikusa M, Ida T, Ozawa K, Tobe T (1979) The influence of hypoxia and hemorrhage upon adenylate energy charge and bile flow. Surg Gynecol Obstet 149:346-352
28. Kimoto M, Shimahara Y, Ikai I, Wakashiro S, Ozaki N, Tatsumi Y, Tanaka A, Kamiyama Y, Yamaoka Y, Ozawa K (1989) The effects of PGI2 analog (OP-41483) on perfused porcine liver. Artif Organs 3:204-208
29. Higgs EA, Higgs GA, Moncada S, Vane JR (1977) Prostacyclin (PGI2) inhibits the formation of platelet thrombi in arterioles and venules of the hamster check pouch. Br J Pharmacol 120 (Suppl 4):493-443
30. Dusting GJ, Moncada S, Vane JR (1982) Prostacyclin: its biosynthesis, actions, and clinical potential. Adv Prostaglandin Thromboxane Leukot Res 10:59-106
31. Araki H, Lefer AM (1980) Cytoprotective actions of prostacyclin during hypoxia in the isolated perfused cat liver. Am J Physiol 238:H176-181
32. Guarner F, Fremont Smith M, Prieto J (1985) Cytoprotective effect of prostaglandins on isolated rat liver cells. Liver 5:35-39
33. Monden M, Fortner JG (1982) Twenty-four- and 48-hour canine liver preservation by simple hypothermia with prostacyclin. Ann Surg 196:38-42
34. Kimoto M, Shimahara Y, Ikai I, Wakashiro S, Ozaki N, Tatsumi Y, Yamaoka Y, Ozawa K (1992) The effects of centrifugal pump on liver support system with porcine liver perfusion (in Japanese). Nippon-Geka-Hokan (Arch Jpn Chirur) 61:396-404
35. Kodama M, Tani T, Inoue N (1993) Therapeutic plasmapheresis to treat postoperative hepatic failure: clinical course and therapeutic outcome in Japan (in Japanese). Nippon Geka Gakkai Zasshi (J Jpn Surg Soc) 94:707-713
36. Agishi T, Nakagawa Y, Teraoka S, Kubo K, Nakazato S, Ota K (1994) Plasma exchange as a rescue strategy for hepatic failure. ASAIO J 40:77-79
37. Malchesky PS (1994) Nonbiological liver support: historic overview. Artif Organs 18:342-347
38. LePage EB, Lane R, McKay D, Rozga J, Demetriou AA (1995) Plasma separation for artificial liver support. J Clin Apheresis 10:70-75
39. Platt JL (1998) New directions for organ transplantation. Nature 392:11-17
40. Valdivia LA, Fung JJ, Demetris AJ, Celli S, Pan F, Tsugita M, Starzl TE (1994) Donor species complement after liver xenotransplantation. The mechanism of protection from hyperacute rejection. Transplantation 57:918-922
41. Sandrin MS, McKenzie IF (1994) Gal alpha (1,3)Gal, the major xenoantigen(s) recognised in pigs by human natural antibodies. Immunol Rev 141:169-190
42. Luo Y, Kosanke S, Mieles L, Kobayashi T, Li SF, Niekrasz M, Shimizu A, Ye Y, Colvin RB, Cooper DK (1998) Comparative histopathology of hepatic allografts and xenografts in the nonhuman primate. Xenotransplantation 5:197-206
43. Tector AJ, Chen X, Soderland C, Tchervenkov JI (1998) Complement activation in discordant hepatic xenotransplantation. Xenotransplantation 5:257-261
44. Bach FH, Robson SC, Ferran C, Winkler H, Millan MT, Stuhlmeier KM, Vanhove R, Blakely ML, van der Werf WJ, Hofer E (1994) Endothelial cell activation and thromboregulation during xcnograft rejection. Immunol Rev 141:5-30
45. Saadi S, Platt JL (1995) Transient perturbation of endothelial integrity induced by natural antibodies and complement. J Exp Med 181:21-31
46. Hanazaki K, Kuroda T, Kajikawa S, Shiohara E, Haba Y, Iida F (1994) Prostaglandin E1 protects liver from ischemic damage. J Surg Res 57:380-384
47. Pruitt SK, Kirk AD, Bollinger RR, Marsh HC Jr, Collins BH, Levin JL, Mault JR, Heinle JS, Ibrahim S, Rudolph AR (1994) The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 57:363-370
48. Terajima H, Shirakata Y, Yagi T, Mashima S, Shinohara H, Satoh S, Arima Y, Gomi T, Hirose T, Takahashi R, Ikai I, Morimoto T, Inamoto T, Yamamoto M, Yamaoka Y (1997) Successful long-term xenoperfusion of the pig liver: continuous administration of prostaglandin E1 and insulin. Transplantation 63:507-512
49. Yagi T, Ikai I, Terajima H, Satoh S, Kanazawa A, Shinohara H, Uesugi T, Yoneyama T, Gomi T, Takahashi R, Yamamoto M, Inamoto T, Yamaoka Y (1997) The protective effects of prostaglandin E1 on sinusoidal endothelial cells in xenogeneic pig liver perfusion. J Surg Res 73:28-34
50. Uesugi T, Ikai I, Yagi T, Satoh S, Kanazawa A, Yoneyama T, Takeyama O, Nishitai R, Katura N, Okabe H, Terajima H, Iwata H, Yamaoka Y (1999) Evaluation of ammonia and lidocaine clearance, and galactose elimination capacity of xenoperfused pig livers using a pharmacokinetic analysis. Transplantation 68:209-214
51. Platt JL (1994) A perspective on xenograft rejection and accommodation. Immunol Rev 141:127-149
52. Lehmann TG, Koeppel TA, Kirschfink M, Gebhard MM, Herfarth C, Otto G, Post S (1998) Complement inhibition by soluble complement receptor type 1 improves microcirculation after rat liver transplantation. Transplantation 66:717-722
53. Rosengard AM, Cary NR, Langford GA, Tucker AW, Wallwork J, White DJ (1995) Tissue expression of human complement inhibitor, decay-accelerating factor, in transgenic pigs. A potential approach for preventing xenograft rejection. Transplantation 59:1325-1333
54. McCurry KR, Kooyman DL, Alvarado CG, Cotterell AH, Martin MJ, Logan JS, Platt JL (1995) Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat Med 1:423-427
55. Levy MF, Crippin J, Sutton S, Netto G, McCormack J, Curiel T, Goldstein RM, Newman JT, Gonwa TA, Banchereau J, Diamond LE, Byrne G, Logan J, Klintmalm GB (2000) Liver allotransplantation after extracorporeal hepatic support with transgenic (hCD55/hCD59) porcine livers: clinical results and lack of pig-to-human transmission of the porcine endogenous retrovirus. Transplantation. 69:272-280
56. Danielsson C, Pascual M, French L, Steiger G, Schifferli JA (1994) Soluble complement receptor type 1 (CD35) is released from leukocytes by surface cleavage. Eur J Immunol 24:2725-2731
57. Weisman HF, Bartow T, Leppo MK, Marsh HC Jr, Carson GR, Concino MF, Boyle MP, Roux KH, Weisfeldt ML, Fearon DT (1990) Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249:146-151
58. Homeister JW, Satoh PS, Kilgore KS, Lucchesi BR (1993) Soluble complement receptor type 1 prevents human complement-mediated damage of the rabbit isolated heart. J Immunol 150:1055-1064
59. Satoh S, Terajima H, Yagi T, Kanazawa A, Shinohara H, Gomi T, Uesugi T, Yoneyama T, Ikai I, Takahashi R, Yamamoto M, Yamaoka Y (1997) Humoral injury in porcine livers perfused with human whole blood. Transplantation 64:1117-1123
60. Schneider DL, Sarett HP (1966) Use of the hysterectomy-obtained SPF pig for nutritional studies of the neonate. J Nutr 89:43-48
61. Patience C, Takeuchi Y, Weiss RA (1997) Infection of human cells by an endogenous retrovirus of pigs. Nat Med 3:282-286
62. Stoye JP, Le Tissier P, Takeuchi Y, Patience C, Weiss RA (1998) Endogenous retroviruses: a potential problem for xenotransplantation? Ann NY Acad Sci 862:67-74
63. Bloom ET, Moulton AS, McCoy J, Chapman LE, Patterson AP (1999) Xenotransplantation: the potential and the challenges. Crit Care Nurse 9:76-83
64. Novak K (1998) US FDA to issue new rules on xenotransplantation. Nat Med 4:876
65. Foley DP, Collins BR, Magee JC, Platt JL, Katz E, Harland RC, Meyers WC, Chari RSSO (2000) Bile acids in xenogeneic ex-vivo liver perfusion: function of xenoperfused livers and compatibility with human bile salts and porcine livers. Transplantation 69:242-348